Scott I Abrams

31PUBLICATIONS
84CO-AUTHORS
Tumour immunologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Nov 04, 2026
The chromatin-organizer Satb1 modulates regulatory T cell activity within the tumor microenvironment.

|Sep 26, 2026
Epigenetic Regulation of Sialyltransferase ST6GAL1 Drives Breast Tumor Heterogeneity.

|May 20, 2026
Immunological consequences of chemotherapy: implications for cancer immunotherapy.

|Mar 07, 2026
TP53 mutation is associated with improved disease control in patients with advanced RAS wild-type colorectal adenocarcinoma treated with cetuximab and pembrolizumab.

Christos Fountzilas, Spencer Rosario, Agnieszka K Witkiewicz

|Dec 11, 2024
Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.

Yuhao Shi, Amber McKenery, Melissa Dolan

|Oct 07, 2024
Consequences of the perivascular niche remodeling for tumoricidal T-cell trafficking into metastasis of ovarian cancer.

Danuta Kozbor, Marta Winkler, Nemi Malhotra

Pageof 6

Frequent Collaborators

6 joint publications

Jason B Muhitch

5 joint publications

Mark Long

5 joint publications

Jonathan F Lovell

3 joint publications

Fumito Ito